How can we achieve universal access to low-cost treatment for HIV?

por Hill, Andrew M, Pozniak, Anton L
Publicado 2016

The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries

por Hill, Andrew M, Nath, Sanjay, Simmons, Bryony
Publicado 2017

Estimated costs of production and potential prices for the WHO Essential Medicines List

por Hill, Andrew M, Barber, Melissa J, Gotham, Dzintars
Publicado 2018

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List

por Gotham, Dzintars, Barber, Melissa Joy, Hill, Andrew M
Publicado 2019

Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19

por Pepperrell, Toby, Pilkington, Victoria, Owen, Andrew, Wang, Junzheng, Hill, Andrew M
Publicado 2020

When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank

por Vitoria, Marco, Ford, Nathan, Clayden, Polly, Pozniak, Anton L., Hill, Andrew M.
Publicado 2017

Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?

por Martin, Natasha K, Boerekamps, Anne, Hill, Andrew M, Rijnders, Bart J A
Publicado 2018

Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?

por Rockwood, Neesha, Cerrone, Maddalena, Barber, Melissa, Hill, Andrew M, Pozniak, Anton L
Publicado 2019

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?

por Vitoria, Marco, Hill, Andrew M, Ford, Nathan P, Doherty, Meg, Khoo, Saye H, Pozniak, Anton L
Publicado 2016

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial

por Griesel, Rulan, Zhao, Ying, Simmons, Bryony, Omar, Zaayid, Wiesner, Lubbe, Keene, Claire M, Hill, Andrew M, Meintjes, Graeme, Maartens, Gary
Publicado 2023

Structures of carboxylic acid reductase reveal domain dynamics underlying catalysis

por Gahloth, Deepankar, Dunstan, Mark S., Quaglia, Daniela, Klumbys, Evaldas, Lockhart-Cairns, Michael P., Hill, Andrew M., Derrington, Sasha R., Scrutton, Nigel S., Turner, Nicholas J., Leys, David
Publicado 2017